This Pune based multibagger company is currently trading at an all-time high

resr 5paisa Research Team

Last Updated: 7th September 2023 - 05:09 pm

Listen icon

Shares of this penny stock have soared 767% in the last three years.

Indrayani Biotech is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds. The company also markets and distributes hybrid vegetable seeds manufactured by Hoechst India. This Pune based penny stock company has given exponential returns in the last 3 years.

  • Rs 1,00,000 invested 1 year ago would have become Rs 4,26,650 giving a price return of 326%,   

  • Rs 1,00,000 invested 2 years ago would have become Rs 5,69,210 giving a price return of 469% and,  

  • Rs 1,00,000 invested 3 years ago would have become Rs 8,67,270 giving a price return of 767%.  

Indrayani Biotech is venturing into three verticals which are Engineering, Food and Agriculture, and Healthcare. The growth strategy is largely inorganic through mergers, acquisitions and partnerships. 

On July 22, 2022 the company’s wholly-owned subsidiary IBL Healthcare Ltd has been declared its acquisition plans of Vaasan Medical Center (India) Private Limited (under insolvency), a chain of pharmacy retail stores under the name and style of ‘Vasan Medical Hall’ in Trichy and adjoining districts of Tamil Nadu. 

FY22 saw a turnaround for the company as revenue more than doubled from Rs 21 crore to Rs 58 crore. The company reported a net profit of Rs 4.22 crore against a net loss of Rs (10.89 ) crore last year. 

Shares of Indrayani Biotech on July 26 touched an all-time high of Rs 50.05 in the intraday trades. The last recorded 52-week high and low stand at Rs 49.50 and Rs 11.30. 

At 1.45 pm, the shares of Indrayani Biotech Ltd were quoting at Rs 50.05, up 4.93% or Rs 2.35 per share. 

FREE Trading & Demat Account
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
hero_form

Indian Stock Market Related Articles

List Of Maharatna Companies In India

by Tanushree Jaiswal 9th Jul 2024

Why Quant Mutual Funds Are Outperforming?

by Tanushree Jaiswal 5th Jul 2024

NSE's 90% Cap on SME IPO Listing Prices

by Tanushree Jaiswal 5th Jul 2024

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Want to Use 5paisa
Trading App?